Lazaros Andronis

Reader

Peter AugusteLink opens in a new window

I am an Assistant Professor in Health Economics, and work with a multidisciplinary team who prepares technology appraisal reviews (TARs) commissioned by National Institute for Health and Care Excellence (NICE). I have experience in undertaking systematic reviews and conducting model-based economic evaluations.

Research interests include:

• Health Technology Assessments
• Decision-analytic modelling in various disease areas (e.g. : latent tuberculosis infection, diabetic retinopathy, congenital heart defects in newborns, recurrent breast cancer, recurrent cervical cancer)
• Long-term impacts of interventions used to reduce overweight/obesity in children

Mary Jordan

Research Fellow

I work jointly between Warwick Evidence and Warwick Clinical Trials Unit as a health economist across a variety of projects. These include Technology Assessment Reviews (TARs) on behalf of NICE as well as conducting economic evaluations alongside clinical trials. My background is in Physiotherapy where I spent a decade in clinical practice working both in the NHS and Australian healthcare systems and taught on undergraduate and postgraduate Physiotherapy programmes at University of Birmingham whilst undertaking my MSc in Health Economics and Health policy.

 Research interests include:

• Economic evaluations alongside clinical trials
• Resource use and cost data collection methods
• Methodological developments in preference elicitation

Rebecca Kandiyali

Associate Professor

I joined Warwick Medical School in September 2021 from the University of Bristol where I held a joint post working with the Bristol Trials Centre and the NIHR Research Design Service. In previous years at Bristol, I undertook a programme of work in paediatric burn injury and held a knowledge mobilisation award with the local clinical commissioning group.

In my current role I am working with Warwick Clinical Trials Unit to provide methodological input across a portfolio of studies. I am Chief Investigator of a controlled before and after study which will evaluate the patient benefit and cost-effectiveness of flash glucose monitoring in young people with type 1 diabetes (FLASH).

Research interests include:

• Experimental and observational study design and associated analytical approaches (including exploitation of ‘real world’ data)
• Considerations for health economic analyses for complex interventions and specific settings/ populations
• Public involvement in the quantitative aspects of health economic studies
• Knowledge mobilisation and impact

Iftekhar Khan

Senior Research Fellow

Kamran Khan

Research Fellow

Jason Madan

Professor of Health Economics

I joined WMS in 2012, having worked previously at the universities of Bristol, Sheffield and Aberdeen.

Current projects include:

MILESTONELink opens in a new window - InSPiReLink opens in a new window - WCAHRDLink opens in a new window

Research interests include:

• Bayesian methods in Health Technology Assessment
• Health economics in low and middle income countries
• Economic evaluations (both trial-based and model-based) of healthcare interventions in mental health and infectious diseases (particularly tuberculosis).

Mandy Maredza

Senior Research Fellow

I joined the Warwick Medical School Clinical Trials Unit in 2016 having previously worked as a health economist in South Africa on various projects that aimed to utilise health economic evidence to inform priority setting in health care. Since joining the Unit, I have conducted economic evaluations alongside orthopaedic, critical care and cancer randomised controlled trials. Current projects include: BOOST, UKSTAR, Emerald, Diamonds and Feed1.

Research interests include:

• Economic evaluations alongside clinical trials
• Economic evaluations (both trial-based and model-based) of healthcare interventions in cardiovascular disease (particularly stroke)
• Methodological concerns surrounding the conduct of economic evaluations in low and middle-income countries

James MasonLink opens in a new window

Professor of Health Economics

I am a Health Economist within Warwick Medical School, Director of the Centre for Health Economics at Warwick (CHEW) and an Associate Director within Warwick Clinical Trials Unit (WCTU). I work primarily on the economic analysis of clinical trials, epidemiological designs and statistical analyses.

Research interests are wide-ranging including methods for analysis within clinical trials, economic models, cost-effectiveness of implementation, trial design, systematic review, epidemiological enquiry and evidence-based medicine. Particular areas of experience include gastrointestinal, orthopedic and dermatological conditions.

Research interests include:

• Economic analysis within clinical trials
• Economic models
• Cost-effectiveness of implementation
• Trial design
• Systematic review
• Epidemiological enquiry
• Evidence-based medicine

Hema MistryLink opens in a new window

Associate Professor

Seyran Naghdi

Research Fellow

I joined Warwick Clinical Trials Unit (WCTU) in December 2021 as a Research Fellow and then the Centre for Health Economics at Warwick (CHEW) in March 2023. Having worked on a Network Meta-analysis for an NIHR HTA project on pharmacological interventions for managing people with chronic migraine and also a qualitative study for the ARTISAN trial. Currently, I am doing economic evaluation analyses for two trials, including Big Baby and OPAL.

 Research interests include:

• Systematic review and (network) meta-analysis
• Economic Evaluation alongside RCTs
• Model-based economic evaluation

Henry Nwankwo

Assistant Professor

I am an Assistant Professor in Health Economics currently working on clinical trials involving orthopaedic interventions and modelling-based studies at Warwick CTU. I joined WMS from the University of Birmingham where I undertook a PhD in the economics of end of life care.

 Research interests include:

• End of life care
• Mental health
• Trial and model-based economic evaluation
• Methodological issues in both trial and model-based economic evaluation.
• The use of capability measures for economic decision making
• The use of economic measures to inform priority setting and decision making in a global context

Professor of Health Economics (Honorary)

Stavros Petrou

Prior to this appointment, I was employed as a health economist by the University of Oxford, worked for the National Perinatal Epidemiology Unit (NPEU), and held a joint affiliation between the NPEU and the University of Oxford's Health Economics Research Centre (HERC). I remain a research associate at the Department of Public Health, University of Oxford.

Here at Warwick I work collaboratively across Warwick Medical School and with and colleagues in the University's Economics Department, which is widely regarded as one of the top university Economics Departments in the UK and Europe in terms of its teaching and research. I conduct my research both alongside large Phase III clinical trials and within health technology appraisal reviews. I pursue a methodological and applied research agenda on economic aspects of health conditions studied.

Research interests include:

• Economic aspects of perinatal and paediatric health and health care;
• The development of utility measurement in these contexts;
• Methodological concerns surrounding the conduct of economic evaluation alongside randomised controlled trials.

Applications from potential PhD students wishing to work in these areas are welcome.

Xia Wang-Steverding

Research Fellow (Honorary)

Xia Wang-Steverding is a health economist and a senior public health researcher based at the Warwick Medical School, University of Warwick working on the Human African Trypanosomiasis modelling and Economic Predictions for Policy (HAT MEPP) project. Her research interests include decision analysis and modelling, costs and patient outcomes, as well as health service research and diseases prevention. She is a member of Cochrane, an external expert of EU Cost and Member of the Global Burden of Disease collaborator network; has previously accomplished many successfully projects of WHO, World Bank, EU Cost, EU FP6, NIHR, UNIEF and the British Society for Antimicrobial Chemotherapy in Biomedical Research Centre etc. in UK, Germany and China.

Mandana Zanganeh

Assistant Professor

Home

PhD Students

People

Research

Publications

Contact us

News